What nephrologists need to know about hemophagocytic syndrome
- 5 May 2009
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 5 (6) , 329-336
Abstract
Hemophagocytic syndrome (HPs) is a rare but distinct condition caused by inappropriate and dysregulated activation of the immune system. HPs is characterized by febrile hepatosplenomegaly, pancytopenia, hypofibrinemia and liver dysfunction; these changes are associated with the infiltration of bone marrow and organs by nonmalignant macrophages that phagocytose blood cells. Primary HPs is linked to inherited immune dysregulation, whereas secondary HPs tends to be triggered by an infectious or neoplastic disease. Multiorgan failure can complicate this life-threatening condition and renal involvement has frequently been reported; however, precise descriptions of the renal manifestations of HPs are lacking. Acute kidney injury due to tubular necrosis is the most common renal presentation, but nephrotic syndrome can also occur. HPs can be observed in immunocompromised patients and nephrologists must be aware that this condition can occur in renal transplant recipients. Mortality in patients with HPs can be as high as 50%. Despite considerable advances in the treatment of familial HPs, no specific therapy has demonstrated a consistent capacity to control reactive HPs when combined with suppression of the triggering factor. This review summarizes the presentation, causes, pathophysiology and renal features of HPs for the benefit of the practicing nephrologist.Keywords
This publication has 65 references indexed in Scilit:
- Successful use of the anti‐CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosisAmerican Journal of Hematology, 2008
- Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus MeetingJournal of Clinical Oncology, 2007
- Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Down-Regulates Tumor Necrosis Factor-α (TNF-α) Receptor-1 and Confers Resistance to TNF-α-Induced Apoptosis in T CellsThe American Journal of Pathology, 2007
- Success with infliximab in treating refractory hemophagocytic lymphohistiocytosisAmerican Journal of Hematology, 2005
- Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3)Cell, 2003
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999
- Association of Hypercytokinemia in the Development of Severe Preeclampsia in a Case of Hemophagocytic SyndromeSeminars in Thrombosis and Hemostasis, 1999
- Haemophagocytic-histiocytic syndrome in renal transplantationNephrology Dialysis Transplantation, 1997
- COURSE OF HEMOPHAGOCYTIC HISTIOCYTIC SYNDROME IN RENAL TRANSPLANT PATIENTSTransplantation, 1995
- Hyperferritinemia in Malignant Histiocytosis and Virus-Associated Hemophagocytic SyndromeNew England Journal of Medicine, 1987